Diabetes 01/14
Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration
AI Enhances Prediction and Identification of Type 2 Diabetes Subtypes Using Basic Glucose Monitoring
Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases
The Transformative Potential of AI in Healthcare: Assessing Prospects and Challenges
CES 2025: AI, Health Wearables, And Smart Glasses Take Center Stage
AI Wants to be the Future of Drug Discovery
AI Tool Parses Diabetes Subtypes Using Continuous Glucose Monitors
Researchers use AI to help predict and identify subtypes of Type 2 diabetes from simple glucose monitor
Doctor Targeted by Deepfake Ad Scam